| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Sep―21 |
Use of kidneys from SARS-CoV-2 infected donors |
Monica Wang |
| 2 |
[GO] |
2023―Feb―18 |
Use of convalescent plasma in the treatment of COVID-19 |
Michael J. Joyner, Nigel Paneth, Arturo Casadevall |
| 3 |
[GO] |
2023―Feb―18 |
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’ |
Naoka Murakami, Robert Hayden, Thomas Hills, Hanny Al-Samkari, Jonathan Casey, Lorenzo Del Sorbo, Patrick R. Lawler, Meghan Sise, David E. Leaf |
| 4 |
[GO] |
2023―Feb―06 |
Author Correction: Therapeutic advances in COVID-19 |
Naoka Murakami, Robert Hayden, Thomas Hills, Hanny Al-Samkari, Jonathan Casey, Lorenzo Del Sorbo, Patrick R. Lawler, Meghan E. Sise, David E. Leaf |
| 5 |
[GO] |
2023―Jan―18 |
Informing clinical decision making during a pandemic - a call for better preparedness |
Priya Vart, Luuk B. Hilbrands, Ron T. Gansevoort |
| 6 |
[GO] |
2022―Nov―01 |
Long COVID: long-term health outcomes and implications for policy and research |
Ziyad Al-Aly, Anupam Agarwal, Nisreen Alwan, Valerie A. Luyckx |
| 7 |
[GO] |
2022―Oct―29 |
AngII autoantibodies after SARS-CoV-2 infection |
Monica Wang |
| 8 |
[GO] |
2022―Oct―17 |
Therapeutic advances in COVID-19 |
Naoka Murakami, Robert Hayden, Thomas Hills, Hanny Al-Samkari, Jonathan Casey, Lorenzo Del Sorbo, Patrick R. Lawler, Meghan E. Sise, David E. Leaf |
| 9 |
[GO] |
2022―Sep―20 |
Author Correction: Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions |
Duvuru Geetha, Andreas Kronbichler, Megan Rutter, Divya Bajpai, Steven Menez, Annemarie Weissenbacher, Shuchi Anand, Eugene Lin, Nicholas Carlson, Stephen Sozio, Kevin Fowler, Ray Bignall, Kathryn Ducharlet, Elliot K. Tannor, Eranga Wijewickrama, Muhammad I. A. Hafidz, Vladimir Tesar, Robert Hoover, Deidra Crews, Charles Varnell, Lara Danziger-Isakov, Vivekanand Jha, Sumit Mohan, Chirag Parikh, Valerie Luyckx |
| 10 |
[GO] |
2022―Aug―24 |
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions |
Duvuru Geetha, Andreas Kronbichler, Megan Rutter, Divya Bajpai, Steven Menez, Annemarie Weissenbacher, Shuchi Anand, Eugene Lin, Nicholas Carlson, Stephen Sozio, Kevin Fowler, Ray Bignall, Kathryn Ducharlet, Elliot K. Tannor, Eranga Wijewickrama, Muhammad I. A. Hafiz, Vladimir Tesar, Robert Hoover, Deidra Crews, Charles Varnell, Lara Danziger-Isakov, Vivekanand Jha, Sumit Mohan, Chirag Parikh, Valerie Luyckx |
| 11 |
[GO] |
2022―Aug―23 |
Vaccination in patients with kidney failure: lessons from COVID-19 |
Nina Babel, Christian Hugo, Timm H. Westhoff |
| 12 |
[GO] |
2022―Apr―13 |
COVID-19 and kidney disease: insights from epidemiology to inform clinical practice |
Viyaasan Mahalingasivam, Guobin Su, Masao Iwagami, Mogamat Razeen Davids, James B. Wetmore, Dorothea Nitsch |
| 13 |
[GO] |
2022―Apr―12 |
COVID-19 vaccine hesitancy |
Eve Dubé, Noni E. MacDonald |
| 14 |
[GO] |
2022―Feb―21 |
Potential SARS-CoV-2 kidney infection and paths to injury |
Luise Hassler, Daniel Batlle |
| 15 |
[GO] |
2021―Dec―06 |
The COVID-19 pandemic: progress in nephrology |
María José Soler, Conxita Jacobs-Cachá |
| 16 |
[GO] |
2021―Oct―19 |
COVID-19 vaccination in patients with immunity-mediated kidney disease |
Maria Prendecki, Michelle Willicombe, Stephen P. McAdoo |
| 17 |
[GO] |
2021―Oct―11 |
COVID-19 vaccination in patients receiving dialysis |
Benjamin Wilde, Johannes Korth, Michael Jahn, Andreas Kribben |
| 18 |
[GO] |
2021―Sep―27 |
COVID-19 vaccination in kidney transplant recipients |
Sophie Caillard, Olivier Thaunat |
| 19 |
[GO] |
2021―Sep―09 |
Long COVID and kidney disease |
Sachin Yende, Chirag R. Parikh |
| 20 |
[GO] |
2021―Jul―26 |
Kidney involvement in COVID-19 |
Susan Allison |
| 21 |
[GO] |
2021―Jul―05 |
Pathophysiology of COVID-19-associated acute kidney injury |
Matthieu Legrand, Samira Bell, Lui Forni, Michael Joannidis, Jay L. Koyner, Kathleen Liu, Vincenzo Cantaluppi |
| 22 |
[GO] |
2021―Jun―11 |
Safeguarding dialysis services during the COVID-19 pandemic |
Mayuri Trivedi |
| 23 |
[GO] |
2021―Mar―23 |
Soluble ACE2 in SARS-CoV-2 infection |
Susan Allison |
| 24 |
[GO] |
2021―Feb―09 |
COVID-19 vaccines and kidney disease |
Martin Windpessl, Annette Bruchfeld, Hans-Joachim Anders, Holly Kramer, Meryl Waldman, Laurent Renia, Lisa F. P. Ng, Zhou Xing, Andreas Kronbichler |
| 25 |
[GO] |
2020―Nov―30 |
The COVID-19 pandemic: consequences for nephrology |
Annette Bruchfeld |
| 26 |
[GO] |
2020―Nov―23 |
The seroprevalence of SARS-CoV-2 in patients on haemodialysis |
Viyaasan Mahalingasivam, Laurie Tomlinson |
| 27 |
[GO] |
2020―Nov―02 |
Publisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup |
Mitra K. Nadim, Lui G. Forni, Ravindra L. Mehta, Michael J. Connor, Kathleen D. Liu, Marlies Ostermann, Thomas Rimmelé, Alexander Zarbock, Samira Bell, Azra Bihorac, Vincenzo Cantaluppi, Eric Hoste, Faeq Husain-Syed, Michael J. Germain, Stuart L. Goldstein, Shruti Gupta, Michael Joannidis, Kianoush Kashani, Jay L. Koyner, Matthieu Legrand, Nuttha Lumlertgul, Sumit Mohan, Neesh Pannu, Zhiyong Peng, Xose L. Perez-Fernandez, Peter Pickkers, John Prowle, Thiago Reis, Nattachai Srisawat, Ashita Tolwani, Anitha Vijayan, Gianluca Villa, Li Yang, Claudio Ronco, John A. Kellum |
| 28 |
[GO] |
2020―Oct―19 |
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 |
Luca Perico, Ariela Benigni, Federica Casiraghi, Lisa F. P. Ng, Laurent Renia, Giuseppe Remuzzi |
| 29 |
[GO] |
2020―Oct―15 |
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup |
Mitra K. Nadim, Lui G. Forni, Ravindra L. Mehta, Michael J. Connor, Kathleen D. Liu, Marlies Ostermann, Thomas Rimmelé, Alexander Zarbock, Samira Bell, Azra Bihorac, Vincenzo Cantaluppi, Eric Hoste, Faeq Husain-Syed, Michael J. Germain, Stuart L. Goldstein, Shruti Gupta, Michael Joannidis, Kianoush Kashani, Jay L. Koyner, Matthieu Legrand, Nuttha Lumlertgul, Sumit Mohan, Neesh Pannu, Zhiyong Peng, Xose L. Perez-Fernandez, Peter Pickkers, John Prowle, Thiago Reis, Nattachai Srisawat, Ashita Tolwani, Anitha Vijayan, Gianluca Villa, Li Yang, Claudio Ronco, John A. Kellum |
| 30 |
[GO] |
2020―Sep―14 |
SARS-CoV-2 in the kidney: bystander or culprit? |
Anitha Vijayan, Benjamin D. Humphreys |
| 31 |
[GO] |
2020―Sep―10 |
Haemoperfusion should only be used for COVID-19 in the context of randomized trials |
Edward G. Clark, Swapnil Hiremath, Lauralyn McIntyre, Ron Wald, Gregory L. Hundemer, Michael Joannidis |
| 32 |
[GO] |
2020―Aug―26 |
CKD is a key risk factor for COVID-19 mortality |
Ron T. Gansevoort, Luuk B. Hilbrands |
| 33 |
[GO] |
2020―Aug―12 |
The impact of COVID-19 on kidney transplantation |
Sami Alasfar, Robin K. Avery |
| 34 |
[GO] |
2020―Aug―11 |
Author Correction: COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19 |
Juan Carlos Q. Velez, Tiffany Caza, Christopher P. Larsen |
| 35 |
[GO] |
2020―Aug―05 |
Impact of the COVID-19 pandemic on clinical research |
Katherine R. Tuttle |
| 36 |
[GO] |
2020―Aug―04 |
COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19 |
Juan Carlos Q. Velez, Tiffany Caza, Chirstopher P. Larsen |
| 37 |
[GO] |
2020―Jul―16 |
The impact of coronavirus in Brazil: politics and the pandemic |
Daniela Ponce |
| 38 |
[GO] |
2020―Jun―19 |
Mental health of health-care workers in the COVID-19 era |
Neil Greenberg |
| 39 |
[GO] |
2020―May―14 |
COVID-19: implications for immunosuppression in kidney disease and transplantation |
Andreas Kronbichler, Philipp Gauckler, Martin Windpessl, Jae Il Shin, Vivekanand Jha, Brad H. Rovin, Rainer Oberbauer |
| 40 |
[GO] |
2020―Apr―24 |
SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2 |
Susan J. Allison |
| 41 |
[GO] |
2020―Apr―09 |
Kidney involvement in COVID-19 and rationale for extracorporeal therapies |
Claudio Ronco, Thiago Reis |
| 42 |
[GO] |
2020―Apr―06 |
Minimizing the risk of COVID-19 among patients on dialysis |
T. Alp Ikizler, Alan S. Kliger |
| 43 |
[GO] |
2020―Apr―03 |
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic |
Andrew M. South, Laurie Tomlinson, Daniel Edmonston, Swapnil Hiremath, Matthew A. Sparks |
|
